Safety and antitumor activity of recombinant soluble Apo2 ligand.
Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z, Schwall RH.
Ashkenazi A, et al. Among authors: koeppen h.
J Clin Invest. 1999 Jul;104(2):155-62. doi: 10.1172/JCI6926.
J Clin Invest. 1999.
PMID: 10411544
Free PMC article.